Citation Impact
Citing Papers
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
Independent gradient model based on Hirshfeld partition: A new method for visual study of interactions in chemical systems
2022 Standout
Engineered Biosynthesis of β‐Alkyl Tryptophan Analogues
2018 StandoutNobel
Pharmaceutical Particle Engineering via Spray Drying
2007 Standout
Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group
2004 Standout
Dipyridamole, an Underestimated Vascular Protective Drug
2005
Glucagon-Like Peptide-1 and Its Class B G Protein–Coupled Receptors: A Long March to Therapeutic Successes
2016
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
2007 StandoutNature
Pathophysiology of oxidative stress in diabetes mellitus
2001
Cl–π interactions in protein–ligand complexes
2008
Characterization of Glycosaminoglycan (GAG) Sulfatases from the Human Gut Symbiont Bacteroides thetaiotaomicron Reveals the First GAG-specific Bacterial Endosulfatase
2014
A challenging system: Free energy prediction for factor Xa
2011
Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial
2018
Evidence for CCl/CBr⋅⋅⋅π Interactions as an Important Contribution to Protein–Ligand Binding Affinity
2009
Vitamin C as an Antioxidant: Evaluation of Its Role in Disease Prevention
2003 Standout
Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
2021
Network pharmacology: the next paradigm in drug discovery
2008 Standout
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
Traumatic brain injury
2000 Standout
Molecular mechanical study of halogen bonding in drug discovery
2011
Design of novel aminopyrrolidine factor Xa inhibitors from a screening hit
2009
Nonbonding interactions of organic halogens in biological systems: implications for drug discovery and biomolecular design
2010
Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
2013 Standout
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
2010 Standout
SwissParam: A fast force field generation tool for small organic molecules
2011 Standout
Halogen bonding for rational drug design and new drug discovery
2012
Halogen bonding and other σ-hole interactions: a perspective
2013 Standout
New G-protein-coupled receptor crystal structures: insights and limitations
2008 StandoutNobel
Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer
2012
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Capturing the energetics of water insertion in biological systems: The water flooding approach
2012 StandoutNobel
Methylene blue derivatives — suitable photoantimicrobials for blood product disinfection?
2000
Selective and orally bioavailable phenylglycine tissue factor/factor VIIa inhibitors
2005
Design of selective phenylglycine amide tissue factor/factor VIIa inhibitors
2004
The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities
2015 Standout
Cation–π Interactions at the Active Site of Factor Xa: Dramatic Enhancement upon Stepwise N‐Alkylation of Ammonium Ions
2008
The Discovery and Development of Liraglutide and Semaglutide
2019
Implications of the guidelines for the management of severe head injury for the practicing neurosurgeon
1998
Dose-dependent antithrombotic activity of an orally active tissue factor/factor VIIa inhibitor without concomitant enhancement of bleeding propensity
2006
Moderate and severe traumatic brain injury in adults
2008 Standout
Expression, Crystallization, and Three-dimensional Structure of the Catalytic Domain of Human Plasma Kallikrein
2005
SPR-based Fragment Screening: Advantages and Applications
2007
The discovery of fluoropyridine-based inhibitors of the factor VIIa/TF complex—Part 2
2005
Bicyclic Peptides with Optimized Ring Size Inhibit Human Plasma Kallikrein and its Orthologues While Sparing Paralogous Proteases
2012 StandoutNobel
Glucagon-like peptide-1 receptor agonists: a systematic review of comparative effectiveness research
2017
Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial
2021
Fragment-based lead discovery: leads by design
2005
Surgical decompression for traumatic brain swelling: indications and results
1999
CSAR Benchmark Exercise 2013: Evaluation of Results from a Combined Computational Protein Design, Docking, and Scoring/Ranking Challenge
2015 StandoutNobel
Halogen Bonding in Supramolecular Chemistry
2015
Tirzepatide Once Weekly for the Treatment of Obesity
2022 Standout
G Protein-Coupled Receptor 119 (GPR119) Agonists for the Treatment of Diabetes: Recent Progress and Prevailing Challenges
2015
Engineered Biosynthesis of β‐Alkyl Tryptophan Analogues
2018 StandoutNobel
Factor Xa Inhibitors: Next-Generation Antithrombotic Agents
2010
Engineering enzymes for noncanonical amino acid synthesis
2018 StandoutNobel
Indian Herbs and Herbal Drugs Used for the Treatment of Diabetes
2007 Standout
Management of Severe Traumatic Brain Injury by Decompressive Craniectomy
2000
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Recent Developments in Isocyanide Based Multicomponent Reactions in Applied Chemistry
2005 Standout
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
ZINC: A Free Tool to Discover Chemistry for Biology
2012 Standout
The Origin of Chalcogen-Bonding Interactions
2017 Standout
A Phase 2, Randomized, Dose-Finding Study of the Novel Once-Weekly Human GLP-1 Analog, Semaglutide, Compared With Placebo and Open-Label Liraglutide in Patients With Type 2 Diabetes
2015
CSAR Benchmark Exercise of 2010: Combined Evaluation Across All Submitted Scoring Functions
2011
Once-Weekly Semaglutide in Adults with Overweight or Obesity
2021 Standout
Fluorine in medicinal chemistry: Recent therapeutic applications of fluorinated small molecules
2006 Standout
Contribution of Explicit Solvent Effects to the Binding Affinity of Small‐Molecule Inhibitors in Blood Coagulation Factor Serine Proteases
2011
Antimicrobial photodynamic therapy – what we know and what we don’t
2018 Standout
In situclick chemistry: a powerful means for lead discovery
2006 StandoutNobel
Formylglycine, a Post-Translationally Generated Residue with Unique Catalytic Capabilities and Biotechnology Applications
2014 StandoutNobel
Formation of ring-in-ring complexes between crown ethers and rigid TVBox8+
2014 StandoutNobel
Cardiovascular Complications After Renal Transplantation and Their Prevention
2006
Unusual Amino Acids in Medicinal Chemistry
2016
The Halogen Bond
2016 Standout
Role of the Active-Site Solvent in the Thermodynamics of Factor Xa Ligand Binding
2008
Decompressive Bifrontal Craniectomy in the Treatment of Severe Refractory Posttraumatic Cerebral Edema
1997
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
Free radicals and antioxidants in human health: current status and future prospects.
2004 Standout
OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins
2015 Standout
Chalcogen Bonding: An Overview
2018 Standout
Principles and Applications of Halogen Bonding in Medicinal Chemistry and Chemical Biology
2012 Standout
A Medicinal Chemist’s Guide to Molecular Interactions
2010 Standout
MANAGEMENT OF ENDOCRINE DISEASE: Are all GLP-1 agonists equal in the treatment of type 2 diabetes?
2019
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
2011 Standout
Methylene blue‐treated fresh‐frozen plasma: what is its contribution to blood safety?
2003
Delivery of therapeutic levels of heparin and low-molecular-weight heparin through a pulmonary route
2004
Works of M. Lorenz being referenced
Novel factor Xa inhibitors based on a 2-carboxyindole scaffold: SAR of P4 substituents in combination with a neutral P1 ligand
2004
Custom chemical microarray production and affinity fingerprinting for the S1 pocket of factor VIIa
2004
Traumatic Brain Swelling and Operative Decompression: A Prospective Investigation
1990
Description of the chemical and pharmacological characteristics of a new hemisynthetic ultra‐low‐molecular‐weight heparin, AVE5026
2009
Design, synthesis, and structure–activity relationship of a new class of amidinophenylurea-based factor VIIa inhibitors
2003
Anaemia after renal transplantation
2005
Novel factor Xa inhibitors based on a benzoic acid scaffold and incorporating a neutral P1 ligand
2004
Effects of lixisenatide once daily on gastric emptying in type 2 diabetes — Relationship to postprandial glycemia
2013
Differential effects of glucagon-like peptide-1 receptor agonists on heart rate
2017
Factor Xa inhibitors based on a 2-carboxyindole scaffold: SAR of neutral P1 substituents
2004
Accumulation of radiolabelled platelets and fibrin on the carotid artery of rabbits after angioplasty: effects of heparin and dipyridamole
2003
Structure-based design of amidinophenylurea-derivatives for factor VIIa inhibition
2004
Recent progress and future options in the development of GLP-1 receptor agonists for the treatment of diabesity
2013
High Doses of Methylene Blue/Light Treatment Crosslink the A-Alpha-Subunit of Fibrinogen: Influence of This Photooxidization on Fibrinogen Binding to Platelets
1998
Approaches in anticoagulation: rationales for target positioning.
2003
Probing the Subpockets of Factor Xa Reveals Two Binding Modes for Inhibitors Based on a 2-Carboxyindole Scaffold: A Study Combining Structure-Activity Relationship and X-ray Crystallography
2005